Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance

A.A.M. van der Veldt, G. Luurtsema, J.M. Lubberink, A.A. Lammertsma, N.H. Hendrikse

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2914-2931
JournalCurrent Pharmaceutical Design
Volume14
Issue number28
DOIs
Publication statusPublished - 2008

Cite this